Lactobacillus plantarum 299v for the Treatment of Recurrent Clostridium difficile-associated Diarrhoea: A Double-blind, Placebo-controlled Trial

By Wullt Marlene   Hagslätt Marie-louise Johansson   Odenholt Inga  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 6-7, 2003-08 ,pp. : 365-367

Informa Healthcare

Access to resources Recommend Favorite

Fidaxomicin versus Vancomycin as a First‐Line Treatment for Clostridium difficile–Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 37, Iss. 12, 2017-12 ,pp. : 1489-1497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

By Garborg Kjetil   Waagsbø Bjørn   Stallemo Asbjørn   Matre Jon   Sundøy Anders  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 11-12, 2010-12 ,pp. : 857-861

Informa Healthcare

Access to resources Recommend Favorite

Risk Factors for Recurrence of Clostridium Difficile-associated Diarrhea in the Elderly

By Tal Sari   Gurevich Alexander   Guller Vladimir   Gurevich Irina   Berger David   Levi Shmuel  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 8, 2002-08 ,pp. : 594-597

Informa Healthcare

Access to resources Recommend Favorite

Frequency and risks associated with Clostridium difficile‐associated diarrhea after pediatric solid organ transplantation: a single‐center retrospective review

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 706-713

John Wiley & Sons Inc

Access to resources Recommend Favorite